Read articles from North America

October 12, 2026 by washingtonexaminer.com

The FDA review backlog is not just an administrative problem; it shapes the market smokers actually face. Legal smoke-free products wait in uncertainty, while illicit and unapproved products move faster than the system designed to regulate them. That imbalance leaves adult smokers with fewer accountable options and gives the black market more space to grow. Product review should be rigorous, but it also has to be timely enough to support harm reduction in the real world.

October 09, 2026 by regulatorwatch.com

A reset of the FDA’s PMTA process is overdue if regulation is meant to guide the market rather than paralyse it. The current pathway has left many smoke-free products trapped in uncertainty while cigarettes remain legally available and illicit alternatives gain space. A better system should be rigorous, transparent and fast enough to distinguish responsible products from those that do not meet standards. Harm reduction depends on regulation that can make timely decisions, not one that delays safer options out of reach.

October 09, 2026 by pearlsandirritations.com

Australia’s nicotine policy is drifting further from the reality consumers are living in. Cigarettes remain legal, illicit tobacco is expanding, and many vapers are navigating workarounds, informal supply or rules that do not match how people actually quit smoking. That gap matters because policy cannot reduce harm effectively while pretending demand has disappeared or that restriction equals control. A better approach would start from real behaviour: keep people inside legal channels, make safer alternatives accessible, and measure success by fewer people smoking.

October 09, 2026 by clearingtheair.eu

Europe’s nicotine debate is becoming a house divided. Some countries are moving towards risk-proportionate regulation, while others are pushing bans, higher taxes and restrictions that may leave cigarettes in a stronger position. That split matters because smokers across Europe are not facing the same chances to move away from combustion. A coherent EU strategy should protect young people, recognise product differences and make the lower-risk route easier to take than the deadly one.

October 08, 2026 by clearingtheair.eu

Estonia’s smoking rate falling by more than a quarter while vaping more than triples is a trend policymakers should examine closely. It suggests a shift in nicotine use that may be moving some adults away from combustible tobacco rather than simply adding new use. The important question is not whether vaping increased in isolation, but what happened to smoking at the same time. Regulation should protect young people and maintain product standards, while recognising that movement away from cigarettes can be a meaningful public health gain.

October 08, 2026 by 2firsts.com

The FDA’s tobacco centre reworking its product review process matters because the current system has struggled to keep pace with the market it is supposed to regulate. Slow, uncertain pathways can leave responsible products waiting while cigarettes remain widely available and unapproved alternatives continue to circulate. A better review model should be faster without becoming weaker: clear standards, transparent decisions and evidence assessed according to relative risk. The goal should be a legal market where safer nicotine products are reviewed in time to help smokers move away from combustion.

October 08, 2026 by 2firsts.com

The FDA’s tobacco centre reworking its product review process matters because the current system has struggled to keep pace with the market it is supposed to regulate. Slow, uncertain pathways can leave responsible products waiting while cigarettes remain widely available and unapproved alternatives continue to circulate. A better review model should be faster without becoming weaker: clear standards, transparent decisions and evidence assessed according to relative risk. The goal should be a legal market where safer nicotine products are reviewed in time to help smokers move away from combustion.

October 07, 2026 by substack.com

Public health loses authority when it treats disagreement as a threat rather than a test of its own claims. In nicotine policy, declaring one position beyond challenge can shut out evidence on relative risk, consumer behaviour and the unintended effects of restriction. Confidence is not the same as accountability. Institutions earn trust by showing their reasoning, correcting errors and allowing policy to be questioned when real-world outcomes do not match the promise.

October 07, 2026 by clearingtheair.eu

One hundred and twenty thousand lived experiences should be difficult for policymakers to ignore. Behind the EU nicotine consultation are smokers, vapers, pouch users and people who have already changed their risk by moving away from cigarettes. Their evidence is not laboratory data, but it is evidence of how policy works in real life. Europe’s next nicotine framework should listen to those experiences before deciding which products adults are allowed to understand, access or use.

October 06, 2026 by gfn.tv

Better regulation begins with a simple discipline: look at the evidence before deciding what the policy should say. In tobacco and nicotine control, that means distinguishing between products, measuring actual exposure, and asking whether rules help smokers move away from combustion. Regulation that ignores evidence may still look decisive, but it can harden the wrong incentives and leave the greatest harms untouched. The challenge is not more regulation for its own sake — it is regulation that is proportionate, responsive and honest about risk.